Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 24, 1999

View Archived Issues

NicOx IPO Seeking $80M For Nitric-Oxide Treatments

NeuroSearch Plans Phase II Trials Of Depression Drug

Pharma Companies Unite To Fight Parallel Imports

Findings On Low-Oxygen Cell Survival Could Mean Improved Heart Treatments

Biovector's IPO Called Off After Lead Banker Pulls Out

Cobra Therapeutics Plans Financing For Cancer Drug

Amrad Investors Hopeful Despite Half-Year Losses

New CD-ROM Educates Teens About Biotechnology

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.